Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug1876 | Ibrutinib Wiki | 0.71 |
drug2916 | Placebo Wiki | 0.04 |
Name (Synonyms) | Correlation | |
---|---|---|
D055370 | Lung Injury NIH | 0.19 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
The purpose of this study is to develop a program to reduce mental health disparities for racial and ethnic minority Veterans. The research program is led by VA peer navigators who are trained specifically to deliver the study intervention. The specific aims of the program are to enhance navigation of mental health services, increase patient engagement, and improve patient-provider communication. Study participants will be randomized into one of two study groups, which will determine when they receive the study intervention. Regardless of study group, participants will have the opportunity to receive services in addition to their regular mental health treatment (either immediately after enrollment into the study or after a 6-month waiting period). Participants will be asked to complete study questionnaires at different timepoints throughout the study to assess their overall satisfaction with the study program and the mental health services that they receive. Participants will also complete an interview to discuss their experience in the study program.
Description: Patient Activation Measure -Mental Health (PAM-MH) is a 13-item scale assessing patient knowledge, skills, and confidence for self-management. The questions are rated on a 4-point Likert-type scale.
Measure: Patient Activation Measure- Mental Health (PAM-MH) Change Time: Change from Baseline to 3 months, to 6 months, to 9 months, and to 12 monthsDescription: Patient Activation Measure- Altarum Consumer Engagement (ACE) is a 12-item scale assessing patient knowledge, skills, and confidence in using the health care system. The questions are rated on a 4-point Likert-type scale.
Measure: Altarum Consumer Engagement (ACE) Change Time: Change from Baseline to 3 months, to 6 months, to 9 months, and to 12 monthsDescription: The SDM-Q9 PARTNER-MH was adapted from Braddock et al.'s informed decision-making scale. The measure is made up of three different sections: the first captures a brief description of the respondent's most recent mental health care appointment along with the decisions that were made during that appointment; the second assesses the extent to which shared decision-making occurred in the appointment (rating nine statements from completely disagree (1) to completely agree (6)); and the third looks at the respondent's attitudes about share decision-making during the appointment.
Measure: SDM-Q9 PARTNER-MH Time: Change from Baseline to 3 months, to 6 months, to 9 months, and to 12 months ChangeDescription: The CollaboRATE measure is a 3-item scale assessing participant efforts to engage in shared decision making during their most recent mental health appointment. The questions are rated on a 10-point Likert-type scale, ranging from 0 (no effort was made) to 10 (every effort was made).
Measure: CollaboRATE (SDM) Time: Change from Baseline to 3 months, to 6 months, to 9 months, and to 12 months ChangeDescription: Peer Coaching Experience Satisfaction Questionnaire is designed to collect feedback on a respondent's overall experience with a peer coach at the end of a 6-month period. The questionnaire explores topics such as number of contacts with the peer as well as satisfaction with the peer contacts and relationship with the peer.
Measure: Peer Coaching Experience Satisfaction Questionnaire Change Time: Adminstered after completion of the study program (6 months for Active PARTNER-MH and 12 months for Waitlist Control)Description: Satisfaction with Services questionnaire is a 13-item survey assessing a respondent's perceptions of their experience with the services that have been provided to them during the study. 11 items are rated on a 3-point Likert type scale, with answers ranging from 1 (not at all) to 3 (very). Two additional items are open answer and ask respondents to describe what they liked the most and least about the services received.
Measure: Satisfaction with Services Questionnaire Responses Change Time: Change from Baseline to 3 months, to 6 months, to 9 months, and to 12 monthsDescription: The Veterans Rand 12-item Health Survey (VR-12) is a 12-item scale that assesses Veterans' report of health-related quality of life. It measures eight components: physical functioning, social functioning, role limitations due to physical and emotional problems, mental health, energy and vitality, bodily pain, and general perception of health. The VR-12 uses no/yes, and yes, all the time response options.
Measure: Veteran's RAND 12-item Health Survey (VR-12) Change Time: Change from Baseline, to 3 months, to 6 months, to 9 months, and to 12 monthsDescription: Perceived Efficacy in Patient-Physician Interactions Scale (PEPPI-5) measures patients' self-efficacy in obtaining medical information and attention to their chief health concern from a physician. It consists of 5 items, scored on a Likert scale ranging from 1 (not confident at all) to 5 (very confident).
Measure: Perceived Efficacy in Patient-Physician Interactions Scale (PEPPI-5) Change Time: Change from Baseline, to 3 months, to 6 months, to 9 months, and to 12 monthsDescription: Working Alliance Inventory Short-Revised (WAI-SR) assesses the degree of collaboration and connection patients believe they have with their providers. The WAI-SR is a 12-item self-report measure and is scored on a 7-point Likert-type scale ranging from 1 (never) to 7 (always). Questions on the scale include "I am confident in Dr. X's ability to help me," and "Dr. X and I are working on mutually agreed-upon goals."
Measure: Working Alliance Inventory Short-Revised (WAI-SR) Change Time: Change from Baseline, to 3 months, to 6 months, to 9 months, and to 12 monthsDescription: Consumer Assessment of Health Care Providers and Systems (CAHPS) Clinician and Group Survey: The survey was developed by the Agency for HealthCare Research and Quality and is used to measure patient satisfaction with VA services as part of the SAIL facility performance measures. It assesses 5 core categories: 1) access to care; 2) patient-provider communication; 3) care coordination; 4) respect from staff; and 5) patient's ratings of their provider. Responses to the survey are measured on a 4-point Likert scale.
Measure: Consumer Assessment of Health Care Providers and Systems (CAHPS) Clinician and Group Survey Change Time: Change from Baseline, to 3 months, to 6 months, to 9 months, and to 12 monthsDescription: UCLA 3 Item Loneliness Scale (UCLA) is a 3-item clinician-administered scale which measures three dimensions of loneliness: relational connectedness, social connectedness, and self-perceived isolation. The dimensions are rated on a scale ranging from hardly ever to often.
Measure: UCLA 3 Item Loneliness Scale (UCLA) Change Time: Change from Baseline, to 3 months, to 6 months, to 9 months, and to 12 monthsDescription: This survey asks about potential impacts that the coronavirus pandemic may have had on an individual's ability to get healthcare, find social support, their finances, ability to meet basic needs, and their mental and emotional well-being. The survey also asks about the individual's experience with the coronavirus. Respondents are asked to think about their experiences over the past 3 months and rate the degree to which they have been impacted.
Measure: Pain Management Collaboratory (PMC) Coronavirus Pandemic (COVID-19) Measure Change Time: Change from Baseline, to 3 months, to 6 months, to 9 months, and to 12 monthsDescription: Patient Health Questionnaire (PHQ-9) is a 9-item scale assessing the experience and severity of depression symptoms over the last 2 weeks. Respondents are asked to rate their experience of symptoms from not experiencing them at all to experiencing them nearly every day.
Measure: Patient Health Questionnaire (PHQ-9) Change Time: Change from Baseline, to 3 months, to 6 months, to 9 months, and to 12 monthsDescription: Perceived Discrimination in Healthcare questionnaire is a 7-item scale which assesses a respondent's perception of experiences based on their racial background. Respondents are asked to rate their experiences on a 5-point Likert type scale, with answers ranging from 0 (never) to 4 (always).
Measure: Perceived Discrimination in Healthcare Responses Change Time: Change from Baseline, to 3 months, to 6 months, to 9 months, and to 12 monthsDescription: The Trust and Satisfaction Survey is a 5-item scale which assess a respondent's degree of trust toward the VA, VA mental health care services, and the study program. Respondents are asked to rate how much they agree with each of the 5 items (from 1 (strongly disagree) to 5 (strongly agree).
Measure: Trust and Satisfaction Survey Responses Change Time: Change from Baseline, to 3 months, to 6 months, to 9 months, and to 12 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports